Lepu Medical Technology (Beijing) Co., Ltd.
300003
Rang in Aktien
#4745
Established in 1999 and headquartered in Beijing, China, Lepu Medical... Established in 1999 and headquartered in Beijing, China, Lepu Medical Technology is a prominent company dedicated to the research, development, production, and sale of a broad spectrum of medical devices, pharmaceuticals, and healthcare services. The company's extensive medical device portfolio primarily focuses on cardiovascular health. This includes interventional cardiology products such as coronary stents, balloons, catheters, guide wires, and related PCI accessories. It also provides solutions for structural heart diseases, like occluders, vascular plugs, delivery systems, and mechanical heart valves. Lepu Medical offers cardiac rhythm management products, including pacemakers, equipment, leads, and electrophysiology systems, alongside products for off-pump coronary artery bypass grafting and peripheral interventional devices such as PTA balloons and guide wires. Beyond cardiovascular applications, their offerings extend to critical care products like vascular access devices, needle-free connectors, blood samplers, and pressure transducers. The company also provides digital subtraction angiography (DSA) systems (both floor and suspended types), in vitro diagnostic (IVD) equipment and biomarkers, hemodialysis catheters and hollow fiber dialyzers, and general surgery instruments including surgical staplers and endo surgery accessories. In the pharmaceutical sector, Lepu Medical manufactures and distributes medications for various conditions. This encompasses a comprehensive range of cardiovascular drugs designed to treat issues like thrombosis, hyperlipidemia, hypertension, angina, and heart failure. Additionally, they produce beta-lactamase antibiotics and antifungal antimicrobial drugs, central nervous system medications (such as painkillers and antidepressants), treatments for gastric/duodenal ulcers and chronic liver disease, respiratory system drugs, hypoproteinemia drugs, and agents that activate blood circulation. Furthermore, Lepu Medical provides a diverse array of healthcare services. These include precision medicine, remote ECG telemonitoring, and specialized consulting and management centers for cardiovascular diseases. The company is also involved in medical science and technology incubation, equity investment, and offers medical financial services. Its service offerings extend to general health consultation, online pharmacy platforms, sales of household medical equipment, smart medical devices, and the operation of specialized hospitals focusing on cardiovascular care. Lepu Medical actively participates in the establishment and co-construction of cardiac catheterization laboratories (Cath Labs).
Aktienkurs
$1.78
Marktkapitalisierung
$3.15B
Veränderung (1 Tag)
6.19%
Veränderung (1 Jahr)
-30.01%
Land
CN
Handel Lepu Medical Technology (Beijing) Co., Ltd. (300003)
Kategorie
Healthcare
Umsatz von Lepu Medical Technology (Beijing) Co., Ltd. (300003)
Umsatz im Jun 2026 TTM: $916.95M
Laut den aktuellen Finanzberichten von Lepu Medical Technology (Beijing) Co., Ltd. beträgt der derzeitige Umsatz des Unternehmens (TTM) $916.95M. Im Jahr 2023 erzielte das Unternehmen einen Umsatz von $1.13B ein Rückgang im Vergleich zu dem Umsatz im Jahr 2022, der $1.54B betrug. Der Umsatz ist der Gesamtbetrag, den ein Unternehmen durch den Verkauf von Waren oder Dienstleistungen erzielt. Im Gegensatz zum Gewinn werden keine Ausgaben abgezogen.
Umsatzverlauf für Lepu Medical Technology (Beijing) Co., Ltd. von 2006 bis 2026
Umsatz am Ende jedes Jahres
| Jahr | Umsatz | ändert |
|---|---|---|
| 2026 (TTM) | $916.95M | 9.66% |
| 2024 | $836.17M | -25.83% |
| 2023 | $1.13B | -26.70% |
| 2022 | $1.54B | -8.29% |
| 2021 | $1.68B | 36.29% |
| 2020 | $1.23B | 9.92% |
| 2019 | $1.12B | 21.15% |
| 2018 | $924.07M | 32.50% |
| 2017 | $697.43M | 39.64% |
| 2016 | $499.47M | 17.15% |
| 2015 | $426.37M | 58.27% |
| 2014 | $269.40M | 25.38% |
| 2013 | $214.86M | 31.88% |
| 2012 | $162.92M | 12.92% |
| 2011 | $144.28M | 23.66% |
| 2010 | $116.67M | 40.93% |
| 2009 | $82.79M | 43.42% |
| 2008 | $57.72M | 40.97% |
| 2007 | $40.95M | 82.30% |
| 2006 | $22.46M | 0.00% |
Umsatz vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Umsatz | Umsatzunterschied | Land |
|---|---|---|---|
| $46.59B | 4,980.44% |
US
|
|
| $35.48B | 3,769.79% |
IE
|
|
| $25.84B | 2,717.72% |
US
|
|
| $21.00B | 2,189.77% |
US
|
|
| - | - |
DE
|
